1. Adebiyi O, Peters E, Marcoux G, Alaverdashvili M, Halpape K, Lodhi RJ. A survey of Saskatchewan family physicians, psychiatrists and pharmacists assessing barriers in lithium use. J Affect Disord Rep 2021; 6: 00286.
2.
Almeida OP, Etherton-Beer C, Kelty E, Sanfilippo F, Preen DB, Page A. Lithium dispensed for adults aged ≥ 50 years between 2012 and 2021: Analyses of a 10% sample of the Australian Pharmaceutical Benefits Scheme. Am J Geriatr Psychiatry. 2023; 31: 716-25.
3.
Baastrup PC. The use of lithium in manic-depressive psychoses. Compreh Psychiatry 1964; 5: 396-408.
4.
Bohlken J, Riedel-Heller S, Bauer M, Kostev K. Bipolar disorder and outcomes of monotherapy with lithium, valproate, quetiapine, olanzapine, venlafaxine, and citalopram. Pharmacopsychiatry. 2021; 54: 126-30.
5.
Bosi A, Clase CM, Ceriani L, Sjölander A, Fu EL, Runesson B et al. Absolute and relative risks of kidney outcomes associated with lithium vs valproate use in Sweden. JAMA Netw Open. 2023; 6: e2322056.
6.
Bschor T, Adli M, Alda M, Baethge C, Etain B, Glenn T et al. Letter of response to Nabi Z, Stansfeld J, Plöderl M, Wood L, Moncrieff J. Effects of lithium on suicide and suicidal behaviour: a systematic review and meta-analysis of randomised trials. Epidemiol Psychiatr Sci. 2022; 31: e84.
7.
Buspavanich P, Behr J, Stamm T, Schlattmann P, Bschor T, Richter C et al. Treatment response of lithium augmentation in geriatric compared to non-geriatric patients with treatment-resistant depression. J Affect Disord. 2019; 251: 136-140.
8.
Cade JFK. Lithium salts in the treatment of psychotic excitement. Med J Aust 1949; 36: 349-52.
9.
Chen PH, Tsai SY, Chen PY, Pan CH, Su SS, Chen CC et al. Mood stabilizers and risk of all-cause, natural, and suicide mortality in bipolar disorder: A nationwide cohort study. Acta Psychiatr Scand. 2023a; 147: 234-47.
10.
Chen PH, Hsiao CY, Chiang SJ, Shen RS, Lin YK, Chung KH, Tsai SY. Cardioprotective potential of lithium and role of fractalkine in euthymic patients with bipolar disorder. Aust N Z J Psychiatry. 2023b; 57: 104-14.
11.
Chen PH, Hsiao CY, Chiang SJ, Tsai SY. Association of lithium treatment with reduced left ventricular concentricity in patients with bipolar disorder. Psychiatry Clin Neurosci. 2023c; 77: 59-61.
12.
Chen PH, Tsai SY, Pan CH, Chang CK, Su SS, Chen CC et al. Mood stabilisers and risk of stroke in bipolar disorder. Br J Psychiatry. 2019; 215: 409-14.
13.
Chen S, Underwood BR, Jones PB, Lewis JR, Cardinal RN. Association between lithium use and the incidence of dementia and its subtypes: A retrospective cohort study. PLoS Med. 2022; 19: e1003941.
14.
De Montigny C, Grunberg F, Mayer A, Deschenes JP. Lithium induces rapid relief of depression in tricyclic antidepressant nonresponders. Br J Psychiatry 1981; 138: 252-6.
15.
Del Matto L, Muscas M, Murru A, Verdolini N, Anmella G, Fico G et al. Lithium and suicide prevention in mood disorders and in the general population: A systematic review. Neurosci Biobehav Rev. 2020; 116: 142-53.
16.
Díaz-Zuluaga AM, Vélez JI, Cuartas M, Valencia J, Castaño M, Palacio JD et al. Ancestry component as a major predictor of lithium response in the treatment of bipolar disorder. J Affect Disord. 2023; 332: 203-9.
17.
Ercis M, Ozerdem A, Singh B. When and how to use lithium augmentation for treating major depressive disorder. J Clin Psychiatry. 2023; 84: 23ac14813.
18.
Ferensztajn-Rochowiak E, Chłopocka-Woźniak M, Rybakowski JK. Ultra-long-term lithium therapy: all-important matters and a case of successful 50-year lithium treatment. Braz J Psychiatry. 2021; 43: 407-13.
19.
Ferensztajn-Rochowiak E, Rybakowski JK. Long-term lithium therapy: side effects and interactions. Pharmaceuticals 2023; 16: 74.
20.
Fico G, Anmella G, Gomez-Ramiro M, de Miquel C, Hidalgo-Mazzei D, Manchia M et al. Duration of untreated illness and bipolar disorder: time for a new definition? Results from a cross-sectional study. J Affect Disord. 2021; 294: 513-20.
21.
Findling RL, McNamara NK, Pavuluri M, Frazier JA, Rynn M, Scheffer R et al. Lithium for the maintenance treatment of bipolar I disorder: A double-blind, placebo-controlled discontinuation study. J Am Acad Child Adolesc Psychiatry 2019; 58: 287-96.e4
22.
Fornaro M, Maritan E, Ferranti R, Zaninotto L, Miola A, Anastasia A et al. Lithium exposure during pregnancy and the postpartum period: a systematic review and meta-analysis of safety and efficacy outcomes. Am J Psychiatry. 2020; 177: 76-92.
23.
Fountoulakis KN, Tohen M, Zarate CA Jr. Lithium treatment of Bipolar disorder in adults: A systematic review of randomized trials and meta-analyses. Eur Neuropsychopharmacol. 2022; 54: 100-15.
24.
Gomes-da-Costa S, Marx W, Corponi F, Anmella G, Murru A, Pons-Cabrera MT et al. Lithium therapy and weight change in people with bipolar disorder: A systematic review and meta-analysis. Neurosci Biobehav Rev. 2022; 134: 104266.
25.
Gomes FA, Brietzke E, Bauer M, Post RM. A call for improving lithium literacy among clinicians and patients. Int J Bipolar Disord. 2022; 10: 5
26.
Gomes FA, Soleas EK, Kcomt A, Duffy A, Milev R, Post RM et al. Practices, knowledge, and attitudes about lithium treatment: Results of online surveys completed by clinicians and lithium-treated patients. Psychiatr Res. 2023; 164: 335-43.
27.
Greil W, Bardeci M, Müller-Oerlinghausen B, Nievergelt N, Stassen H, Hasler G et al. Controversies regarding Lithium-associated weight gain: case-control study of real-world drug safety data. Int J Bipol Disord 2023; 11: (w druku).
28.
Grillault Laroche D, Etain B, Severus E, Scott J, Bellivier F; ISBD-IGSLI Joint Task Force on Lithium Treatment. Socio-demographic and clinical predictors of outcome to long-term treatment with lithium in bipolar disorders: a systematic review of the contemporary literature and recommendations from the ISBD/IGSLI Task Force on treatment with lithium. Int J Bipolar Disord. 2020; 8: 40.
29.
Güneş H, Tanıdır C, Doktur H, Karaçetin G, Kılıçoğlu AG, Yalçın Ö et al. Long-term effects of lithium use on children and adolescents: a retrospective study from Turkey. J Child Adolesc Psychopharmacol. 2022; 32: 162-70.
30.
Hafeman DM, Rooks B, Merranko J, Liao F, Gill MK, Goldstein TR et al. Lithium versus other mood-stabilizing medications in a longitudinal study of youth diagnosed with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2020; 59:1146-55.
31.
Hartigan GP. The use of lithium salts in affective disorders. Br J Psychiatry 1963; 109: 810-14.
32.
Hidalgo-Mazzei D, Mantingh T, Pérez de Mendiola X, Samalin L, Undurraga J, Strejilevich S et al. Clinicians' preferences and attitudes towards the use of lithium in the maintenance treatment of bipolar disorders around the world: a survey from the ISBD Lithium task force. Int J Bipolar Disord. 2023; 11: 20.
33.
Hsu CW, Carvalho AF, Tsai SY, Wang LJ, Tseng PT, Lin PY et al. Lithium concentration and recurrence risk during maintenance treatment of bipolar disorder: Multicenter cohort and meta-analysis. Acta Psychiatr Scand. 2021; 144: 368-78.
34.
Hsu CW, Tsai SY, Tseng PT, Liang CS, Vieta E, Carvalho AF et al. Differences in the prophylactic effect of serum lithium levels on depression and mania in bipolar disorder: A dose-response meta-analysis. Eur Neuropsychopharmacol. 2022; 58: 20-9.
35.
Izsak B, Hidvegi A, Balint L, Malnasi T, Vargha M, Pandics T et al. Investigation of the association between lithium levels in drinking water and suicide mortality in Hungary. J Affect Disord. 2022; 298(Pt A): 540-47.
36.
Köhler-Forsberg O, Rohde C, Nierenberg AA, Østergaard SD. Association of lithium treatment with the risk of osteoporosis in patients with bipolar disorder. JAMA Psychiatry. 2022; 79: 454-63.
37.
Kraszewska A, Ziemnicka K, Jończyk-Potoczna K, Sowiński J, Rybakowski JK. Thyroid structure and function in long-term lithium-treated and lithium-naïve bipolar patients. Hum Psychopharmacol. 2019; 34: e2708
38.
Liaugaudaite V, Raskauskiene N, Naginiene R, Mickuviene N, Sher L. Association between lithium levels in drinking water and suicide rates: Role of affective disorders. J Affect Disord. 2022; 298(Pt A): 516-21.
39.
Lin Y, Maihofer AX, Stapp E, Ritchey M, Alliey-Rodriguez N, Anand A et al. Clinical predictors of non-response to lithium treatment in the Pharmacogenomics of Bipolar Disorder (PGBD) study. Bipolar Disord. 2021 Dec; 23 (8): 821-31.
40.
López Steinmetz LC, López Steinmetz RL, Diaz SL, Godoy JC. Lithium in drinking water, altitude, and suicide rates in rural areas of Argentinean Andes. Spat Spatiotemporal Epidemiol. 2021; 36: 100393.
41.
Malhi GS, Bauer M. Lithium first: Not merely first line. Bipolar Disord. 2023; 25: 7-8.
42.
McKnight RF, de La Motte de Broöns de Vauvert SJGN, Chesney E, Amit BH, Geddes J, Cipriani A. Lithium for acute mania. Cochrane Database Syst Rev. 2019; 6: CD004048.
43.
Moncrieff J, Cooper RE, Stockmann T, Amendola S, Hengartner MP, Horowitz MA. The serotonin theory of depression: a systematic umbrella review of the evidence. Mol Psychiatry. 2022 Jul 20. doi: 10.1038/s41380-022-01661-0. Online ahead of print.
44.
Nabi Z, Stansfeld J, Plöderl M, Wood L, Moncrieff J. Effects of lithium on suicide and suicidal behaviour: a systematic review and meta-analysis of randomised trials. Epidemiol Psychiatr Sci. 2022; 31: e65.
45.
Ng VWS, Leung MTY, Chan EW, Lee EHM, Hayes JF, Osborn DPJ et al. Association between the mood stabilizing treatment of bipolar disorder and risk of suicide attempts: A self-controlled case series study. Psychiatry Res. 2023; 325: 115236.
46.
Nieper HA. The clinical applications of lithium orotate. A two years study. Agressologie. 1973; 14: 407-11.
47.
Nolen WA, Licht RW, Young AH, Malhi GS, Tohen M, Vieta E et al. What is the optimal serum level for lithium in the maintenance treatment of bipolar disorder? A systematic review and recommendations from the ISBD/IGSLI Task Force on treatment with lithium. Bipolar Disord 2019; 21: 394-09.
48.
Pacholko AG, Bekar LK. Different pharmacokinetics of lithium orotate inform why it is more potent, effective, and less toxic than lithium carbonate in a mouse model of mania. J Psychiatr Res. 2023; 164: 192-201.
49.
Palmer A, Cates ME, Gorman G. The association between lithium in drinking water and incidence of suicide across 15 Alabama counties. Crisis. 2019; 40: 93-9.
50.
Pelacchi F, Dell’Osso L, Bondi E, Amore M, Fagiolini A, Iazzetta P et al. Clinical evaluation of switching from immediate-release to prolonged-release lithium in bipolar patients, poorly tolerant to lithium immediate-release treatment: A randomized clinical trial. Brain Behav. 2022; 12: e2485.
51.
Pérez de Mendiola X, Hidalgo-Mazzei D, Vieta E, González-Pinto A. Overview of lithium’s use: a nationwide survey. Int J Bipolar Disord. 2021; 9: 10.
52.
Poels EM, Sterrenburg K, Wierdsma AI, Wesseloo R, Beerthuizen A, van Dijke L et al. Lithium exposure during pregnancy increases fetal growth. J Psychopharmacol. 2021; 35: 178-83.
53.
Poels EMP, Schrijver L, White TJH, Roza SJ, Zarchev MG, Bijma H et al. The effect of prenatal lithium exposure on the neuropsychological development of the child. Bipolar Disord. 2022; 24: 310-19.
54.
Poels EMP, Kamperman AM, Bijma HH, Honig A, van Kamp IL, Kushner SA et al. Brain development after intrauterine exposure to lithium: A magnetic resonance imaging study in school-age children. Bipolar Disord. 2023; 25: 181-90.
55.
Ponzer K, Millischer V, Schalling M, Gissler M, Lavebratt C, Backlund L. Lithium and risk of cardiovascular disease, dementia and venous thromboembolism. Bipolar Disord. 2023 Jan 18. doi: 10.1111/bdi.13300. Online ahead of print.
56.
Rhee TG, Olfson M, Nierenberg AA, Wilkinson ST. 20-year trends in the pharmacologic treatment of bipolar disorder by psychiatrists in outpatient care settings. Am J Psychiatry. 2020; 177: 706-15.
57.
Rohde C, Köhler-Forsberg O, Nierenberg AA, Østergaard SD. Pharmacological treatment of bipolar disorder and risk of diabetes mellitus: A nationwide study of 30,451 patients. Bipolar Disord. 2023; 25: 323-34.
58.
Romo-Nava F, Blom T, Cuellar-Barboza AB, Barrera FJ, Miola A, Mori NN et al. Clinical characterization of patients with bipolar disorder and a history of asthma: An exploratory study. J Psychiatr Res. 2023; 164: 8-14.
59.
Rybakowski J, Chłopocka M, Lisowska J, Czerwiński A. Badania nad skutecznością leczniczą węglanu litu w endogennych zespołach depresyjnych. Psychiatr Pol 1974; 8: 129-35.
60.
Rybakowski J. Leczenie litem – stan wiedzy na rok 2020. Psychiatr Pol 2020; 54: 1047-66.
61.
Rybakowski J. Lit – niezwykły lek w psychiatrii. Wydawnictwo Termedia, Poznań, 2019. https://www.termedia.pl/Ksiazka/-279
62.
Rybakowski JK, Ferensztajn-Rochowiak E. Mini-review: Anomalous association between lithium data and lithium use. Neurosci Lett. 2022; 777: 136590.
63.
Rybakowski JK, Ferensztajn-Rochowiak E. Updated perspectives on how and when lithium should be used in the treatment of mood disorders. Expert Rev Neurother 2023; 23: 157-167.
64.
Sagué-Vilavella M, Solé E, Pinzón-Espinosa J, Sandra-Hernández A, Roda E, Vieta E, Roca A. Obstetric outcomes regarding the use of lithium in pregnant women with bipolar disorders: a prospective cohort study. Arch Womens Ment Health. 2022; 25: 729-37.
65.
Scherf-Clavel M, Treiber S, Deckert J, Unterecker S, Hommers L. Drug-drug interactions between lithium and cardiovascular as well as anti-inflammatory drugs. Pharmacopsychiatry. 2020; 53: 229-34.
66.
Schonewille NN, Terpstra PA, van den Heuvel MEN, Van Pampus MG, van den Heuvel OA, Broekman BFP. Neonatal admission after lithium use in pregnant women with bipolar disorders: a retrospective cohort study. Int J Bipolar Disord. 2023; 11: 24.
67.
Schoot TS, Molmans THJ, Grootens KP, Kerckhoffs APM. Systematic review and practical guideline for the prevention and management of the renal side effects of lithium therapy. Eur Neuropsychopharmacol. 2020; 31: 16-32.
68.
Schoretsanitis G, de Filippis R, Brady BM, Homan P, Suppes T, Kane JM. Prevalence of impaired kidney function in patients with long-term lithium treatment: A systematic review and meta-analysis. Bipolar Disord. 2022; 24: 264-74.
69.
Shafiq S, Ronksley PE, Scory TD, Elliott MJ, Bulloch AGM, Patten SB. Ten-year trends in lithium prescribing in Alberta, Canada. Can J Psychiatry. 2023: 7067437231176905. doi: 10.1177/07067437231176905. Online ahead of print.
70.
Shulman KI, Almeida OP, Herrmann N, Schaffer A, Strejilevich SA, Paternoster C et al. Delphi survey of maintenance lithium treatment in older adults with bipolar disorder: An ISBD task force report. Bipolar Disord. 2019; 21: 117-23.
71.
Singh B, Yocum AK, Strawbridge R, Burdick KE, Millett CE, Peters AT et al. Patterns of pharmacotherapy for bipolar disorder: A GBC survey. Bipolar Disord. 2023 Jul 18. doi: 10.1111/bdi.13366. Online ahead of print.
72.
Undurraga J, Sim K, Tondo L, Gorodischer A, Azua E, Tay KH et al. Lithium treatment for unipolar major depressive disorder: Systematic review. J Psychopharmacol 2019; 33: 167-76.
73.
Velosa J, Delgado A, Finger E, Berk M, Kapczinski F, de Azevedo Cardoso T. Risk of dementia in bipolar disorder and the interplay of lithium: a systematic review and meta-analyses. Acta Psychiatr Scand. 2020; 141: 510-21.
